Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision metadata updated from v3.6.5 to v3.6.6, signaling a new release version. No user-facing content is affected by this change.SummaryDifference0.0%

- Check20 days agoChange DetectedAn NIH grant/contract line (2014 ( U.S. NIH Grant/Contract )) was added to the study's external identifiers. This addition provides an explicit funding reference associated with the trial.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of the previous v3.6.4, indicating a minor site-release update.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform-level update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.6.3 is now shown, replacing v3.6.0. This reflects a backend update to the site rather than changes to the study details.SummaryDifference0.0%

- Check91 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label; recruitment status now states 'No longer looking for participants', and the page revision is updated to v3.6.0.SummaryDifference0.1%

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.